跳至主要内容
临床试验/JPRN-UMIN000032591
JPRN-UMIN000032591已完成2 期

The study of feasibility and usefulness of olanzapine for the patients who received oxaliplatin chemotherapy. - The study of feasibility and usefulness of olanzapine for the patients who received oxaliplatin chemotherapy.

Osaka International Cancer Institute0 个研究点目标入组 40 人开始时间: 2018年5月15日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who has severe dysfunction of liver or kidney 2. Patients who suffered nausea or vomiting before 24 h of the enrollment 3. Patients who used antiemetics before 24 h of the enrollment 4. Patients with symptomatic brain metastasis/carcinomatosis. 5. Patients who had diabetes. 6. Pregnant, breastfeeding or expecting woman. 7. Patient is receiving pimozide 8. Patient is judged inappropriate by the investigator as subject for this study

研究者

相似试验